HOME >> BIOLOGY >> NEWS
Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis

This release is available in Spanish.

Glycine is a non-essential amino acid used by the organism to synthesise proteins and is present in foods such as fish, meat or dairy products. The study, carried out at the Cellular Metabolism Institute in Tenerife and at the Department of Biochemistry and Molecular Biology of the University of Granada by Doctor Patricia de Paz Lugo and supervised by Doctors Enrique Melndez Hevia, David Melndez Morales and Jos Antonio Lupiez Cara, established that the direct intake of this substance as a food additive helps to prevent arthrosis and other degenerative diseases, in addition to other diseases related to a weakness in the mechanical structure of the organism, including the difficulty of repairing physical injuries.

The work of De Paz Lugo was developed at the Cellular Metabolism Institute (CMI) in Tenerife, where researchers studied the effect of the glycine supplement on the diet of a group of 600 volunteers affected by different diseases related to the mechanical structure of the organism such as arthrosis, physical injuries or osteoporosis. The patients analysed were aged 4-85, and the average age was 45.

In all cases, there was a notable improvement in the symptomology. Thefore according to De Paz Lugo- we concluded that many degenerative diseases such as arthrosis can be treated as deficiency diseases due to the lack of glycine, since supplementing a diet with this amino acid leads to a notable improvement in symptomology without the need to take pain-killers.

A very common disease

Arthrosis is the most common osteoarticulary problem in our society: more than 50% of the population suffer from it after the age of 65, and 80% of people over 75. It consists of a degeneration of the articulary cartilage which disappears until it leaves the subchondral bon
'"/>

Contact: Dr. Patricia de Paz Lugo
patricia@metabolismo.es
34-922-315-688
Universidad de Granada
6-Aug-2007


Page: 1 2

Related biology news :

1. Taking heart failure to the MAT1
2. Taking chips to the next level of gene hunting
3. Vax and Pax: Taking turns to build an eye
4. Taking evolutions temperature: Researchers pinpoint the energy it takes to make a species
5. Taking a bite out of a fellow worker helps wasps recruit new foragers
6. Taking a break from fractures: A closer look at vitamin D
7. Taking a flying jump
8. Taking the piste out of Alpine vegetation
9. Taking the next step toward growing our own fuel
10. Negative effects of plastics additive blocked by nutrient supplements
11. Dietary calcium is better than supplements at protecting bone health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... (PRWEB) , ... September 11, 2018 , ... ... coatings, is proud to introduce the new ChemXP™ line of high performance secondary ... The line was developed to provide Tennant Coatings’ elite certified installers with the ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its ... directly related to the spine that result from it. The deal will make ...
(Date:8/31/2018)... ... August 30, 2018 , ... ... Research. Jacklyn Novak, infrared materials engineer, LightPath Technologies. In the future, these names ... just celebrated her 100th birthday. Today, they are among 26 scientists whose work ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... ... 28, 2018 , ... CEO and founder of VetStem Biopharma, ... on an allogeneic (donor derived) stem cell product for osteoarthritis in canines at ... September. He is also the organizer of Breakout Session 4: Practitioner Primer on ...
(Date:8/29/2018)... ... 2018 , ... USDM Life Sciences , the leading risk management, technological ... that Manu Vohra will deliver a presentation at the BoxWorks 2018 conference ... for GxP in 30 Days” , When: Thursday, August 30, 1:00-1:50 PM PT, Where: ...
(Date:8/26/2018)... ... August 24, 2018 , ... ExoCoBio ... exosomes dramatically relieves atopic dermatitis and inhibits a variety of inflammatory targets in ... paper, the symptoms of mice having severe atopic dermatitis were significantly improved after ...
(Date:8/23/2018)... , ... August 23, 2018 , ... Visikol ... Co-Founder Dr. Thomas Villani. Through support from advisors, mentors, the Rutgers Technology Transfer team ... , Visikol’s path from an idea to a successful biotech company has been a ...
Breaking Biology Technology:
Cached News: